In addition to its well-established role in influenza treatment, PK-Merz is used as an effective therapeutic agent for Parkinson's disease. It works by antagonistically acting on the NMDA-ion channel in the basal ganglia, thereby providing a comprehensive improvement in the problematic symptoms of rigidity, tremor, and hypokinesia.